According to information on the AADSM website "the American Academy of Dental Sleep Medicine supports new guidelines that identify oral appliance therapy as an effective treatment for obstructive sleep apnea.
A study published in Sleep, "Heavy snoring as a cause of carotid artery atherosclerosis" should alert all health professionals and concerned family members about the dangers of snoring.
Michael Farrell is the global head of ResMed’s Sleep Business Unit. As a Senior Vice President of the second largest maker of CPAP his October 1,2009 announcement that it had acquired Laboratoires Narval (“Narval”) in Lyon. Narval is the French manufacturer and distributer of oral appliances for the treatment of sleep